Goldenberg Dm
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Radiopharmaceutical Chemistry and Applications 15
- Monoclonal and Polyclonal Antibodies Research 13
- Medical Imaging Techniques and Applications 2
- Co-authors
- Primus Fj (7 shared papers)Hansen Hj (1 shared paper)Elliot Alpert (1 shared paper)Sidney Bennett (1 shared paper)Scott E. Casper (2 shared papers)Ellen N. Spremulli (1 shared paper)Norman Estes (1 shared paper)I. Fand (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (30 papers)
- Partner nations
- United States
In The Last Decade
Goldenberg Dm
24 papers receiving 544 citations
Peers
Comparison fields: 5 of 65
- Radiology, Nuclear Medicine and Imaging 487
- Oncology 171
- Pathology and Forensic Medicine 73
- Biotechnology 31
- Immunology 73
Countries citing papers authored by Goldenberg Dm
This map shows the geographic impact of Goldenberg Dm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goldenberg Dm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goldenberg Dm more than expected).
Fields of papers citing papers by Goldenberg Dm
This network shows the impact of papers produced by Goldenberg Dm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goldenberg Dm. The network helps show where Goldenberg Dm may publish in the future.
Co-authors
The 15 scholars most cited alongside Goldenberg Dm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. | 1974 | 157 |
| 2 | Experimental radioimmunotherapy of a xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen. | 1981 | 70 |
| 3 | Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy. | 1988 | 67 |
| 4 | Radioimmunodetection of cancer with radiolabeled antibodies to alpha-fetoprotein. | 1980 | 61 |
| 5 | Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer. | 1979 | 50 |
| 6 | Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies. | 1983 | 46 |
| 7 | Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancer. | 1980 | 26 |
| 8 | Improved experimental cancer therapy by radioantibody dose intensification as a result of syngeneic bone marrow transplantation. | 1995 | 23 |
| 9 | Relationship of radioantibody localization and cell viability in a xenografted human cancer model as measured by whole-body autoradiography. | 1987 | 22 |
| 10 | Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies. | 1991 | 21 |
| 11 | Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies. | 1990 | 16 |
| 12 | Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression. | 1998 | 10 |
| 13 | Xenogeneic antitumor antibodies in cancer radioimmunodetection. | 1980 | 7 |
| 14 | The early vascular reactions to heterotransplanted human tumours in the hamster cheek pouch. | 1967 | 6 |
| 15 | Monoclonal antibody therapy of cancer. | 1990 | 6 |
| 16 | Imaging and therapy of cancer with radiolabeled monoclonal antibodies. | 1989 | 6 |
| 17 | [The use of some new human tumor strains in experimental cancer research. II]. | 1967 | 5 |
| 18 | Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group. | 1997 | 3 |
| 19 | In vivo radioimmunological lymphoscintigraphy in cancer: the implications of positive findings. | 1982 | 3 |
| 20 | In vivo radioimmunodetection of neoplasms. | 1979 | 2 |
About Goldenberg Dm
Goldenberg Dm is a scholar working on Microbiology, Radiology, Nuclear Medicine and Imaging, Transplantation, Oncology and Cancer Research, having authored 31 papers that have together received 617 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Medical Imaging and Pathology Studies (4 papers), Medical Imaging Techniques and Applications (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (487 citations), Oncology (171 citations), Pathology and Forensic Medicine (73 citations), Biotechnology (31 citations) and Immunology (73 citations). Goldenberg Dm has collaborated with scholars based in United States. Frequent co-authors include Primus Fj, Hansen Hj, Elliot Alpert, Sidney Bennett, Scott E. Casper, Ellen N. Spremulli, Norman Estes, I. Fand, Jay L. Hess and S. Witte. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.